Caroline Hynes
Overview
Explore the profile of Caroline Hynes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carolan A, Hynes C, McWilliams S, Ryan C, Strawbridge J, Keating D
Int J Clin Pharm
. 2023 May;
45(5):1299-1301.
PMID: 37212968
People with severe mental illness (SMI) have a shorter life expectancy than the rest of the population. Multimorbidity and poorer physical health contribute to this health inequality. Cardiometabolic multimorbidity confers...
2.
Carolan A, Keating D, McWilliams S, Hynes C, ONeill M, Boland F, et al.
BMC Psychiatry
. 2022 Sep;
22(1):585.
PMID: 36057589
Background: The life expectancy of people with severe mental illness (SMI) is shorter than those without SMI, with multimorbidity and poorer physical health contributing to health inequality. Screening tools could...
3.
Fitzgerald I, OConnell J, Keating D, Hynes C, McWilliams S, Crowley E
Evid Based Ment Health
. 2021 Sep;
25(1):15-22.
PMID: 34588212
Background: Adjunctive metformin is the most well-studied intervention in the pharmacological management of antipsychotic-induced weight gain (AIWG). Although a relatively unaddressed area, among guidelines recommending consideration of metformin, prescribing information...
4.
Hynes C, McWilliams S, Clarke M, Fitzgerald I, Feeney L, Taylor M, et al.
Ther Adv Psychopharmacol
. 2020 Oct;
10:2045125320957119.
PMID: 33029344
Background: Antipsychotics are associated with a range of side-effects that can influence patients' subjective well-being negatively resulting in poor adherence. In order to limit the negative consequences of side-effects, they...
5.
Keating D, McWilliams S, Hynes C, Purcell A, Clarke M, Strawbridge J
Am J Pharm Educ
. 2019 Dec;
83(9):7138.
PMID: 31871345
To develop a model system for involving patients and caregivers in curriculum development of mental health education in an undergraduate pharmacy program. Purposive recruitment was used to convene a focus...
6.
Keating D, McWilliams S, Hynes C, Clarke M, Strawbridge J
Am J Pharm Educ
. 2019 Jul;
83(5):6784.
PMID: 31333259
To create a brief, experiential educational intervention for undergraduate pharmacy students aimed at developing appropriate attitudes, knowledge, and skills for the delivery of recovery-focused pharmacy services to people with mental...
7.
OLeary J, Purcell A, Hynes C, Huet J, Romanos M, McWilliams S
J Clin Psychopharmacol
. 2018 Oct;
38(6):642-644.
PMID: 30334867
No abstract available.
8.
Doyle R, Behan C, OKeeffe D, Masterson S, Kinsella A, Kelly A, et al.
J Clin Psychopharmacol
. 2017 Jun;
37(5):512-517.
PMID: 28650930
Purpose/background: For approximately one third of individuals treated for psychosis or schizophrenia, antipsychotic medications will have little or no therapeutic benefit. Clozapine remains the sole medication approved for treatment-resistant schizophrenia,...
9.
Keating D, McWilliams S, Schneider I, Hynes C, Cousins G, Strawbridge J, et al.
BMJ Open
. 2017 Jan;
7(1):e013881.
PMID: 28062471
Objectives: Clinical practice guidelines (CPGs) support the translation of research evidence into clinical practice. Key health questions in CPGs ensure that recommendations will be applicable to the clinical context in...
10.
Hynes C, Keating D, McWilliams S, Madigan K, Kinsella A, Maidment I, et al.
Schizophr Res
. 2015 Aug;
168(1-2):505-13.
PMID: 26276305
Objective: The authors developed and validated a clozapine-specific side-effects scale capable of eliciting the subjectively unpleasant side-effects of clozapine. Methods: Questions from the original Glasgow Antipsychotic Side-effects Scale (GASS) were...